Venture
Showing 1–30 of 156 results
-
-
VentureABION BIO
-
VentureAbTis – Dong-A ST
AbTis is a leading ADC Biotech Company with the world’s best linker platform technology4. They have developed the 3rd generation of ADC linker technology, AbClick®, which utilizes a cyclic peptide that site-selectively conjugates drugs to natural antibodies without antibody modification. It also controls the number of payloads conjugated to the linker for high yield of conjugation and simple process of purification. Therefore, AbClick® leads cost-effective ADC production with a high therapeutic index.
-
VentureAceBiome
AceBiome, a dietary supplements company supplying probiotics products based on microbiome research, spun out of Bioneer Corporation in 2017 and was founded as a subsidiary of Bioneer.
Lactobacillus gasser BNR17′, researched and developed for about twenty years by the researchers of Bioneer and AceBiome, is the first probiotic strain approved by MFDS (Korea FDA) as a functional ingredient to help reduce body fat, and is currently a globally patented probiotic for weight control and diabetes.
Centered around BNR17′ probiotic products that ameliorate overweight and obesity, AceBiome is a fast-growing, global company that seeks to improve human health and quality of life. -
VentureAimedBio
AIMEDBIO specializes in the clinical development of brain diseases. AIMEDBIO uses its brain-oriented multi-disciplinary platform, consisting of largely five parts – big data, antibody-drug conjugate, blood-brain barrier penetration, brain immune modulation and patient-derived model (PDC/PDX), along the development process of therapeutics for brain diseases.
-
-
VentureAnterogen Co., Ltd.
Anterogen Co., Ltd. is a company that focuses on the development of regenerative medicine and cell therapy products. They are committed to the research and development of new drugs for unmet medical needs.
-
-
-
VentureAPITBIO
APITBIO has monoclonal antibody pipelines, bispecific antibody pipelines, and a CAR-T pipeline under co-development.
-
VentureAprilBio
AprilBio is a company that is developing innovative drugs based on antibody fragment-based source technology.
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
VentureAptaBio
-
VentureAptamer Sciences Inc.
Aptamer Sciences Inc is a company that focuses on the research and experimental development on natural sciences and engineering.
-
VentureAPURES
APURES is a company that focuses on the development of gene therapy drugs. They have been transforming from a company that produced experimental pigs to a company that develops gene therapy drugs. They have also been recognized for their work in the field of cell-based therapies.
-
-
-
VentureAvixgen
-
VentureBioapp
HERBAVAC™ is a plant-derived recombinant subunit vaccine brand of BioApplications Inc.
HERBAVAC™ CSF Green Marker contains
a fusion protein that combines the E2 antigen and CBD (cellulose-binding domain). It does not contain Erns antigen, which is present in field strains and live attenuated vaccines.
Therefore, pigs vaccinated with HERBAVAC™ CSF Green Marker can be easily distinguished from pigs infected with field strains or live vaccinated. -
VentureBiocure Pharm
BiocurePharm is a biopharmaceutical company comprised of leading scientists specializing in the development and commercialization of major biosimilar products.
-
VentureBioLeaders Corporation
-
VentureBioMe
BioMe is a company that was established based on the research results of the Yonsei University College of Medicine. They are challenging to treat respiratory infections, inflammatory bowel disease, colorectal cancer, cardiovascular disease, and antibiotic-resistant bacterial infections with microbiome-based microbial live therapeutics.
-
-
VentureBIONOXX
-
VentureBioOrchestra
BioOrchestra is a bio-leading company that develops innovative RNA-based therapeutics. They are working on a treatment for Alzheimer’s disease, Parkinson’s disease, and ALS4.
-
VentureBiopharmmer
BioPharmer is a company that focuses on innovating novel immunotoxin antibody assets and regulating stem cell fate with cutting-edge technologies.
-
VentureBIOPOA Co., Ltd.
BioPOA is a biotech company that focuses on the development of vaccines and related services for diseases, as well as the development and commercialization of disease diagnostic technologies. They aim to meet various unmet medical needs through the development of innovative medicines.
-
-
VentureBioway
Bioway is a drug development and research company based in South Korea. The company focuses on the development of innovative drugs based on the understanding of the biological aspects of diseases and open innovation. They specialize in analyzing the structure of substances and the correlation with their medicinal effects (SAR data) to develop drug design and new drug candidates.
-
VentureBrexogen
Brexogen is a company that paves innovative cell-free strategies for targeting incurable diseases via stem cell exosome. They have been recognized for their excellent expertise in kinase inhibitors.